ProSolus transdermal and topical patch manufacturing
Transdermal and Prescription Strength Patches
ProSolus Topical Patches

Transdermal Patch and Topical

Formulation, Development, Manufacturing

We’re transforming topical patches and transdermal patch delivery systems.

By developing or in-licensing transdermal patches in a variety of therapeutic categories, our development portfolio includes pain management, cardiovascular, and neurologic care.

What We Do

ProSolus, Inc. delivers sophisticated transdermal and topical patches, customized to exceed your expectations. We formulate, develop, and manufacture high-barrier-to-entry transdermal drug delivery products and topical patches in our state-of-the-art laboratories and manufacturing facility. Our patches are designed with the patient in mind.

How We Do It

Our R&D team works collaboratively with our suppliers to create polymers and design combinations of excipients that improve the absorption of medications through the skin without having to resort to exotic permeation enhancers. Focused on what lies ahead, our team continues to explore methods to optimize delivery.

topical and transdermal patch manufacturing

Partnerships

ProSolus is an experienced partner, with unrivaled transdermal and topical delivery prowess. Our experts are committed to delivering a customized experience every step of the way concept through completion. Whether you need formulation, development, and/or manufacturing support, we’ll provide sophisticated solutions tailored to your needs.

About ProSolus, Inc.

ProSolus, Inc. is a wholly owned subsidiary of Canoa, Inc.  We are focused on formulating and developing high-barrier-to-entry Transdermal Drug Delivery systems (TDDs) for ANDA, NDA, and 505(b)(2) applications.

Our state-of-the art pharma facility in Miami, Florida is managed by a seasoned leadership team with more than 65 years of experience. With a manufacturing wing and 50 million+ transdermal and/or topical patch capacity, ProSolus effectively and efficiently delivers results. Our team is with you from the formulation stage, through the clinical stage, to the coating stage completing the cycle and preparing the product for packaging.

Recent News

Canoa ProSolus Press Release

Canoa Inc. to Acquire Privately-Held ProSolus Inc.

Press Releases

Canoa Inc. to Acquire Privately-Held ProSolus Inc., Accelerating Transdermal Patch Drug Delivery Product Development MIAMI, Florida, August 02, 2019 – Canoa Inc. (“Canoa”), a Delaware corporation with a focus on healthcare and pharmaceuticals, today announced that it has agreed to acquire ProSolus® Inc. (“ProSolus”), from Mission Pharmacal® Company, in an all-cash transaction. ProSolus is a…

Read more
pharmaceutical coater

ProSolus Seeks Higher Utilization of Transdermal Drug Delivery Technology

Products and Projects

ProSolus Seeks Higher Utilization of Transdermal Drug Delivery TechnologyParent company, Mission Pharmacal, expands commitment to patch technology with significant investments in manufacturing and commercial team. Transdermal patch production line at ProSolus, Inc. in Miami Juan Mantelle, ProSolus Chief Operating Officer and Chief Scientific Officer MIAMI, Fla. (April 25, 2017) – ProSolus, Inc. (“ProSolus”) is doubling…

Read more